Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,339,027
-
Share change
-
+1,538,586
-
Total reported value
-
$824,462,207
-
Put/Call ratio
-
72%
-
Price per share
-
$16.71
-
Number of holders
-
159
-
Value change
-
+$27,617,409
-
Number of buys
-
94
-
Number of sells
-
53
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q2 2020
As of 30 Jun 2020,
AIMMUNE THERAPEUTICS INC - COM (AIMT) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,339,027 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Palo Alto Investors LP, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, FIERA CAPITAL CORP, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.